Skip to content
Home/Companies/Biotech/Oxford Nanopore Technologies

Oxford Nanopore Technologies

Biotech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Oxford Nanopore Technologies?

Oxford Nanopore Technologies is a British Biotech company, currently owned by Novo Holdings since 2021. It changed hands in 2021, when IP Group and Amadeus Capital Partners sold.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Novo Holdings
Most recent investor
Novo Holdings
Novo Holdings Growth Investments · 1999 · Growth
3 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusActive

Ownership history

3 ownership periods

Active
Currently held by Novo Holdings since 2021.
IP Group
IP GroupExited 2021
2005 · 2021(16yr) · IP Group (Evergreen) · 2001 · Evergreen
IPO

IP Group took Oxford Nanopore Technologies public via IPO in 2021 after 16 years.

Novo Holdings
2021 · present(5yr) · Novo Holdings Growth Investments · 1999 · Growth
Amadeus Capital Partners
2021 · 2021(<1yr) · Amadeus V Technology Fund · 2021 · VC
IPO · to Novo Holdings

Amadeus Capital Partners took Oxford Nanopore Technologies public via IPO in 2021 after less than a year.

Questions

Who owns Oxford Nanopore Technologies?

Oxford Nanopore Technologies is currently owned by Novo Holdings, through Novo Holdings Growth Investments, since 2021.

When did Novo Holdings acquire Oxford Nanopore Technologies?

Novo Holdings acquired Oxford Nanopore Technologies in 2021.

Who did Oxford Nanopore Technologies sell to?

Amadeus Capital Partners sold Oxford Nanopore Technologies to Novo Holdings in 2021 (IPO).

Who has owned Oxford Nanopore Technologies over time?

Oxford Nanopore Technologies has been through 3 private-equity ownership periods: IP Group · via IP Group (Evergreen) · 2005–2021 · (IPO); Novo Holdings · via Novo Holdings Growth Investments · since 2021; Amadeus Capital Partners · via Amadeus V Technology Fund · 2021–2021 · sold to Novo Holdings · (IPO).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue